Virtus ETF Advisers’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,952
| Closed | -$75.8K | – | 664 |
|
|
2024
Q4 | $75.8K | Sell |
3,952
-3,059
| -44% | -$58.6K | 0.03% | 346 |
|
|
2024
Q3 | $160K | Buy |
7,011
+127
| +2% | +$2.89K | 0.07% | 316 |
|
|
2024
Q2 | $89.6K | Buy |
6,884
+2,405
| +54% | +$31.3K | 0.04% | 361 |
|
|
2024
Q1 | $78.4K | Sell |
4,479
-308
| -6% | -$5.39K | 0.04% | 396 |
|
|
2023
Q4 | $104K | Buy |
4,787
+1,215
| +34% | +$26.5K | 0.07% | 342 |
|
|
2023
Q3 | $54.8K | Sell |
3,572
-358
| -9% | -$5.49K | 0.03% | 410 |
|
|
2023
Q2 | $93.5K | Buy |
3,930
+307
| +8% | +$7.3K | 0.06% | 410 |
|
|
2023
Q1 | $92.2K | Sell |
3,623
-1,394
| -28% | -$35.5K | 0.05% | 355 |
|
|
2022
Q4 | $147K | Buy |
+5,017
| New | +$147K | 0.08% | 352 |
|